ArticleEuropean journal of applied physiology2026
Acute responses of inflammatory markers, glucose, and myoglobin in blood following neuromuscular electrical stimulation.
Article in European journal of applied physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposePhysical inactivity contributes to systemic inflammation and metabolic dysfunction. Neuromuscular electrical stimulation (NMES) offers an alternative to exercise for individuals unable to perform voluntary physical activity. This study investigated whether a single submaximal NMES session alters inflammation-related proteins, muscle-damage markers and glucose levels in healthy adults.
methodsThirty-six healthy adults underwent a 2-hour NMES-session targeting the quadriceps, hamstring and gluteal muscles using wearable NMES-pants. Stimulation was delivered at individually tolerated intensities (visual analogue scale, (0-10), < 4). Venous blood samples were collected immediately before and after NMES. Inflammatory proteins and myoglobin were quantified using OLINK multiplex proteomic panel (92 proteins), and metabolic markers including glucose, lactate, pH and electrolytes were assessed using standard laboratory methods.
resultsOf the 92 inflammatory proteins analyzed, 13 were nominally affected by NMES. After correction for multiple comparison, FMS-like tyrosine kinase 3 ligand (Flt3L) and fibroblast growth factor 19 (FGF19) remained significantly downregulated (Flt3L: 9.45 ± 0.12 to 9.11 ± 0.17, p < 0.001; FGF19; 9.43 ± 0.88 to 8.80 ± 0.84, p < 0.001; both normalized protein expression (NPX)). Myoglobin increased (7.70 ± 0.50 to 8.24 ± 0.83 NPX; p < 0.001), while blood glucose decreased modestly (5.35 ± 0.73 to 5.17 ± 0.36 mmol/L; p = 0.039). Lactate, pH, sodium and potassium remained unchanged.
conclusionA single submaximal NMES-session elicited acute systemic responses characterized by downregulation of key inflammation-related proteins, mild myoglobin elevation and lower glucose levels - changes that mirror patterns observed after moderate exercise. These findings suggest that NMES at well-tolerated submaximal intensities can induce metabolic adaptations and may represent a safe, exercise-mimicking intervention to counteract inflammation and metabolic dysfunction in individuals with limited physical activity.
Indexed as
Identifiers
41925840What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.